Montis Biosciences

Develops novel immuno-oncology therapeutics targeting the intersection between vascular dysfunction and immune suppression to treat solid tumors

Visit Website

World leader in IgE drugs with a pipeline of therapies to treat solid cancer tumours

Visit Website
Oxford BioTherapeutics

Pipeline of first in class oncology drugs leveraging a proprietary database

Visit Website